Editorial: MicroRNA-33 Inhibition: A Potential Adjunct to Statin Therapy?

Curr Vasc Pharmacol. 2016;14(4):321-2. doi: 10.2174/1570161114999160513150737.

Authors

Amirhossein Sahebkar¹, Pamela Maffioli, Maciej Banach, Giuseppe Derosa

Affiliation

¹ Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, P.O. Box: 91779-48564, Iran. sahebkara@mums.ac.ir.

PMID: 27173024
DOI: 10.2174/1570161114999160513150737

No abstract available

Publication types

Editorial

MeSH terms

Animals
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
MicroRNAs / metabolism*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
MicroRNAs